We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

5 hedge funds and large institutions have $1.3M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 81 → 5 (-76)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 76

100% less capital invested

Capital invested by funds: $501M → $1.3M (-$499M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-76
Holders Change %
-93.83%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
76
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FWM
Focused Wealth Management
New York
+$1.25K

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$53.3M
2
SAM
Sandell Asset Management
New York
-$43.9M
3
OP
Omni Partners
United Kingdom
-$43.4M
4
JP Morgan Chase
JP Morgan Chase
New York
-$28.8M
5
OAM
Oxford Asset Management
United Kingdom
-$22.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
JG
26
Jefferies Group
New York
– -$6.02M -154,728 Closed
SCM
27
Segantii Capital Management
Hong Kong
– -$5.94M -152,676 Closed
SAM
28
Sectoral Asset Management
Quebec, Canada
– -$5.75M -147,756 Closed
Bank of America
29
Bank of America
North Carolina
– -$5.22M -134,306 Closed
WAM
30
Wolverine Asset Management
Illinois
– -$4.36M -112,208 Closed
Renaissance Technologies
31
Renaissance Technologies
New York
– -$4.14M -106,500 Closed
GKIM
32
GW&K Investment Management
Massachusetts
– -$3.78M -97,120 Closed
UBS Group
33
UBS Group
Switzerland
– -$3.75M -96,452 Closed
PCM
34
Prelude Capital Management
New York
– -$3.56M -91,533 Closed
SMC
35
S. Muoio & Co
New York
– -$3.42M -87,950 Closed
State Street
36
State Street
Massachusetts
– -$3.02M -77,578 Closed
RG
37
Redmile Group
California
– -$2.98M -76,729 Closed
OM
38
Opaleye Management
Massachusetts
– -$2.72M -70,000 Closed
Deutsche Bank
39
Deutsche Bank
Germany
– -$2.62M -67,300 Closed
KC
40
Kellner Capital
New York
– -$2.55M -65,600 Closed
CI
41
Cowen Inc
New York
– -$2.86M -64,000 Closed
KAM
42
Kassirer Asset Management
Ontario, Canada
– -$2.33M -59,989 Closed
Vanguard Group
43
Vanguard Group
Pennsylvania
– -$2.14M -55,015 Closed
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
– -$1.95M -50,160 Closed
PAMP
45
Polar Asset Management Partners
Ontario, Canada
– -$1.95M -50,000 Closed
Northern Trust
46
Northern Trust
Illinois
– -$1.91M -49,134 Closed
HA
47
Havens Advisors
New York
– -$1.78M -45,750 Closed
GI
48
GAMCO Investors
Connecticut
– -$1.51M -38,810 Closed
DCM
49
DAFNA Capital Management
California
– -$1.48M -37,938 Closed
MTCM
50
Mint Tower Capital Management
Netherlands
– -$1.43M -36,783 Closed
1
2
3 4

NDRM Hedge Fund Activity: Q4 2017 in Review

5 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2017, worth a combined $1.3M — down 100% from $501M a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of NDRM and 1 opened new positions — a net loss of 75 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Focused Wealth Management, opening a new position worth an estimated $1.25K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $53.3M sold.

  • 5 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2017, down from 81 in Q3 2017.
  • Funds reported $1.3M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2017, down 100% quarter-over-quarter.
  • 1 fund opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2017 and 76 closed out, a net change of -75 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2017 was Focused Wealth Management, an estimated $1.25K added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2017 was AQR Arbitrage, an estimated $53.3M sold.

Based on aggregated 13F filings for Q4 2017.